| Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ... Cell 161 (7), 1681-1696, 2015 | 2883 | 2015 |
| Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy CS Hinrichs, ZA Borman, L Gattinoni, Z Yu, WR Burns, J Huang, ... Blood, The Journal of the American Society of Hematology 117 (3), 808-814, 2011 | 389 | 2011 |
| Cell surface lactate receptor GPR81 is crucial for cancer cell survival CL Roland, T Arumugam, D Deng, SH Liu, B Philip, S Gomez, WR Burns, ... Cancer research 74 (18), 5301-5310, 2014 | 309 | 2014 |
| Validation of the American Joint Commission on Cancer (AJCC) staging system for patients with pancreatic adenocarcinoma: a Surveillance, Epidemiology and End Results (SEER … SK Kamarajah, WR Burns, TL Frankel, CS Cho, H Nathan Annals of surgical oncology 24, 2023-2030, 2017 | 288 | 2017 |
| A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer D Abate-Daga, KH Lagisetty, E Tran, Z Zheng, L Gattinoni, Z Yu, ... Human gene therapy 25 (12), 1003-1012, 2014 | 224 | 2014 |
| Neoadjuvant cabozantinib and nivolumab converts locally advanced HCC into resectable disease with enhanced antitumor immunity. WJ Ho, Q Zhu, J Durham, A Popovic, S Xavier, J Leatherman, A Mohan, ... Nature cancer 2 (9), 891-903, 2021 | 177 | 2021 |
| Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells RE Beard, Z Zheng, KH Lagisetty, WR Burns, E Tran, SM Hewitt, ... Journal for immunotherapy of cancer 2, 1-11, 2014 | 157 | 2014 |
| Neuroendocrine pancreatic tumors: guidelines for management and update WR Burns, BH Edil Current treatment options in oncology 13, 24-34, 2012 | 146 | 2012 |
| Differentiated thyroid cancer WR Burns, MA Zeiger Seminars in oncology 37 (6), 557-566, 2010 | 129 | 2010 |
| Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase TL Frankel, WR Burns, PD Peng, Z Yu, D Chinnasamy, JA Wargo, ... The Journal of Immunology 184 (11), 5988-5998, 2010 | 124 | 2010 |
| A high molecular weight melanoma-associated antigen–specific chimeric antigen receptor redirects lymphocytes to target human melanomas WR Burns, Y Zhao, TL Frankel, CS Hinrichs, Z Zheng, H Xu, SA Feldman, ... Cancer research 70 (8), 3027-3033, 2010 | 121 | 2010 |
| Patient-derived organoid pharmacotyping is a clinically tractable strategy for precision medicine in pancreatic cancer TT Seppälä, JW Zimmerman, E Sereni, D Plenker, R Suri, N Rozich, ... Annals of surgery 272 (3), 427-435, 2020 | 94 | 2020 |
| Lack of specific γ-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation WR Burns, Z Zheng, SA Rosenberg, RA Morgan Blood, The Journal of the American Society of Hematology 114 (14), 2888-2899, 2009 | 92 | 2009 |
| Recruitment of CXCR3+ and CCR5+ T cells and production of interferon-γ-inducible chemokines in rejecting human arteries WR Burns, Y Wang, PCY Tang, H Ranjbaran, A Iakimov, J Kim, M Cuffy, ... American journal of transplantation 5 (6), 1226-1236, 2005 | 90 | 2005 |
| Interferon‐γ plays a nonredundant role in mediating T‐cell‐dependent outward vascular remodeling of allogeneic human coronary arteries Y Wang, WR Burns, PCY Tang, T Yi, JS Schechner, HG Zerwes, ... The FASEB journal 18 (3), 606-608, 2004 | 84 | 2004 |
| Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity WJ Ho, Q Zhu, J Durham, A Popovic, S Xavier, J Leatherman, A Mohan, ... Nature Cancer 2 (9), 891-903, 2021 | 75 | 2021 |
| Perioperative outcomes of robotic pancreaticoduodenectomy: a propensity-matched analysis to open and laparoscopic pancreaticoduodenectomy AF van Oosten, D Ding, JR Habib, A Irfan, RK Schmocker, E Sereni, ... Journal of Gastrointestinal Surgery 25 (7), 1795-1804, 2021 | 68 | 2021 |
| Precision medicine in pancreatic cancer: patient-derived organoid pharmacotyping is a predictive biomarker of clinical treatment response TT Seppälä, JW Zimmerman, R Suri, H Zlomke, GD Ivey, A Szabolcs, ... Clinical Cancer Research 28 (15), 3296-3307, 2022 | 64 | 2022 |
| Periadventitial dissection of the superior mesenteric artery for locally advanced pancreatic cancer: surgical planning with the “halo sign” and “string sign” JR Habib, B Kinny-Köster, F van Oosten, AA Javed, JL Cameron, ... Surgery 169 (5), 1026-1031, 2021 | 55 | 2021 |
| Completion lymph node dissection or radiation therapy for sentinel node metastasis in Merkel cell carcinoma JS Lee, AB Durham, CK Bichakjian, PW Harms, JA Hayman, SA McLean, ... Annals of surgical oncology 26, 386-394, 2019 | 51 | 2019 |